Geode Capital Management’s Modular Medical MODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128K Buy
64,095
+11,450
+22% +$33.3K ﹤0.01% 4000
2026
Q2
$237K Buy
52,645
+25,158
+92% +$115K ﹤0.01% 3855
2026
Q1
$145K Buy
27,487
+10,021
+57% +$107K ﹤0.01% 4024
2025
Q4
$191K Buy
17,466
+119
+0.7% +$1.75K ﹤0.01% 3923
2025
Q3
$364K Buy
17,347
+3,617
+26% +$77.9K ﹤0.01% 3726
2025
Q2
$307K Buy
13,730
+192
+1% +$5.13K ﹤0.01% 3726
2025
Q1
$443K Buy
13,538
+2,834
+26% +$94.5K ﹤0.01% 3587
2024
Q4
$440K Buy
10,704
+489
+5% +$28.3K ﹤0.01% 3639
2024
Q3
$690K Buy
10,215
+3,169
+45% +$171K ﹤0.01% 3484
2024
Q2
$334K Buy
7,046
+2,211
+46% +$108K ﹤0.01% 3727
2024
Q1
$268K Buy
4,835
+1,634
+51% +$87.8K ﹤0.01% 3837
2023
Q4
$175K Hold
3,201
– – ﹤0.01% 3987
2023
Q3
$111K Buy
+3,201
New +$102K ﹤0.01% 4212

Other funds holding MODD

Geode Capital Management's MODD Position: Q3 2026 in Review

Geode Capital Management increased its Modular Medical (MODD) stake by 22% in Q3 2026, buying an estimated $33.3K and bringing the position to 64,095 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #4000.

Geode Capital Management first reported a position in MODD in Q3 2023 and has held it in 13 quarters since. The position peaked at $690K in Q3 2024. 7 funds tracked by Wall St. Rank hold MODD as of Q3 2026.

  • Geode Capital Management held 64,095 shares of Modular Medical worth $128K as of Q3 2026.
  • Geode Capital Management bought 11,450 Modular Medical shares in Q3 2026, an estimated $33.3K.
  • Modular Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4000 holding.
  • Geode Capital Management first reported a position in Modular Medical in Q3 2023 and has held it in 13 quarters since.
  • Geode Capital Management's Modular Medical position peaked at $690K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Modular Medical as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.